Vasoactive intestinal peptide induction by ciliary neurotrophic factor in donor human corneal endothelium in situ.
After peripheral nerve axotomy, vasoactive intestinal peptide (VIP) gene expression is upregulated in neurons, whereas ciliary neurotrophic factor (CNTF) accumulates extracellularly at the lesion site. Although CNTF-induced VIP gene expression has been reported in cultured sympathetic neurons and neuroblastoma cells, it still remains to be determined if CNTF and VIP play interrelated roles in nerve injury. The corneal endothelium, like sympathetic neurons, derives from the neural crest. Previously, we demonstrated that a sublethal-level of oxidative stress induces CNTF release from corneal endothelial (CE) cells in situ. Here, we show that human CE cells express the 53 kDa ligand-binding alpha subunit of the CNTF receptor (CNTFRalpha). We further demonstrate that CNTF induces VIP immunoreactivity in human donor corneas. To determine if the increase in VIP immunoreactivity was reflected by an increase in gene expression, donor human corneas were bisected and treated with CNTF or vehicle, and analyzed by real-time RT-qPCR. Two experiments using different sets of bisected corneas indicated that CNTF induced increases in VIP mRNA levels of 6.5+/-2.2-fold (N=7 corneas) and 2.3+/-0.6-fold (N=10 corneas) (mean+/-S.E.M.), respectively. Whereas VIP is produced as a CE autocrine factor against oxidative stress, the present study suggested that oxidative stress-released CNTF plays a role in protecting CE cells against oxidative stress injury by upregulating VIP expression.
Koh
Shay-Whey M
SW
Department of Ophthalmology & Visual Sciences, University of Maryland, Baltimore, United States. skoh@umaryland.edu
Guo
Yan
Y
Bernstein
Steve L
SL
Waschek
James A
JA
Liu
Xiuhuai
X
Symes
Aviva J
AJ
D020934:Ciliary Neurotrophic Factor / Q000378:metabolism*; D004728:Endothelium, Corneal / Q000378:metabolism*; D015870:Gene Expression; D005786:Gene Expression Regulation; D006801:Humans; D012333:RNA, Messenger / Q000032:analysis; D018005:Receptors, Vasoactive Intestinal Peptide / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014660:Vasoactive Intestinal Peptide / Q000096:biosynthesis*
D020934:Ciliary Neurotrophic Factor; D012333:RNA, Messenger; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide
Arch Ophthalmol. 2000 Jun;118(6):757-60
10865310
J Neurosci. 2006 Dec 27;26(52):13523-30
17192435
Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2887-96
12202507
Peptides. 2003 Jan;24(1):163-77
12576099
J Neurosci Res. 2003 Oct 15;74(2):240-7
14515353
Pharmacol Rev. 2004 Jun;56(2):249-90
15169929
Science. 1979 Jun 29;204(4400):1434-6
451576
Exp Eye Res. 1979 Jul;29(1):27-43
510425
Dev Biol. 1982 Aug;92(2):470-5
7117695
Ophthalmology. 1982 Jun;89(6):531-90
7122038
Exp Eye Res. 1985 Nov;41(5):665-8
4092758
Nature. 1989 Dec 21-28;342(6252):920-3
2594085
Nature. 1990 May 31;345(6274):440-1
2342575
Dev Biol. 1992 Apr;150(2):281-93
1372570
J Cell Biol. 1992 Jul;118(1):139-48
1618901
Brain Res. 1992 Jun 5;582(1):47-57
1379873
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):572-6
8093644
J Neurochem. 1994 Aug;63(2):429-38
7518494
Mol Endocrinol. 1994 Dec;8(12):1750-63
7708062
Dev Neurosci. 1995;17(1):1-7
7621745
J Neurosci. 1995 Nov;15(11):7377-85
7472491
J Neurochem. 1996 Oct;67(4):1751-60
8858962
Exp Eye Res. 1997 Aug;65(2):241-8
9268592
Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2781-9
9418731
Curr Eye Res. 2005 Mar;30(3):189-94
15804744
J Neurobiol. 2005 Jun;63(3):215-34
15719421
Exp Neurol. 2006 Jan;197(1):206-14
16226750
Clin Experiment Ophthalmol. 2005 Dec;33(6):642-57
16402960
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3896-901
16505355
Nat Immunol. 2006 Apr;7(4):354-9
16550198
Invest Ophthalmol Vis Sci. 2000 Dec;41(13):4085-92
11095600